MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2

Downregulation of the CCK-B receptor in pancreatic cancer cells blocks proliferation and promotes apoptosis

(2012) Kristin K. Fino et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancer

(2012) Jill P. Smith et al.   CANCER BIOLOGY & THERAPY

Targeting gastrin for the treatment of gastric acid related disorders and pancreatic cancer

(2011) Magda Morton et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Blocking gastrin and CCK-B autocrine loop affects cell proliferation and apoptosis in vitro

(2010) Jian Jiang Zhou et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma

(2010) Hai-Ying Wan et al.   Molecular Cancer

The CCK2 receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor development

(2010) M Kidd et al.   REGULATORY PEPTIDES

Gastrin increases mcl-1 expression in type I gastric carcinoid tumors and a gastric epithelial cell line that expresses the CCK-2 receptor

(2008) D. M. Pritchard et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Blockade of cholecystokinin-2 receptor and cyclooxygenase-2 synergistically induces cell apoptosis, and inhibits the proliferation of human gastric cancer cells in vitro

(2008) Wei-Hao Sun et al.   CANCER LETTERS

Retracted: TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and invasion in pancreatic cancer

(2008) Zhiwei Wang et al.   INTERNATIONAL JOURNAL OF CANCER